Usefulness of Superparamagnetic Iron Oxide (SPIO) as a Negative Oral Contrast Agent in MR Cholangiopancreatography.
- Author:
Jeong Min LEE
1
;
Won Kyu SONG
;
Chong Deok LEE
Author Information
1. Department of Radiology, Chonbuk National University Hospital.
- Publication Type:Original Article
- Keywords:
MR cholangiopancreatography;
Negative oral contrast;
Superparamagnetic iron oxide (SPIO)
- MeSH:
Biliary Tract;
Common Bile Duct;
Diagnosis;
Duodenum;
Healthy Volunteers;
Humans;
Iron*;
Pancreatic Diseases;
Pancreatic Ducts;
Stomach;
Water
- From:Journal of the Korean Society of Magnetic Resonance in Medicine
2001;5(1):49-56
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To evaluate value of superparamagnetic iron oxide (SPIO) as a negative oral contrast agent in MR cholangiopancreatography (MRCP). MATERIALS AND METHODS: Forty-eight patients with suspected biliary tract or pancreatic diseases and six healthy volunteers were enrolled in this study. All MR images were obtained using a 1.5 T MR unit. MRCP using fat-suppressed half-Fourier acquisition single-shot turbo spin echo (HASTE) and turbo spin echo (TSE) techniques were performed and reconstructed with maximal intensity projection (MIP). To determine the most optimal concentration of SPIO to obliterate the high signal intensity of water, a phantom experiment was conducted with various concentrations of SPIO-water mixture. Two radiologists evaluated pre- and postcontrast MRCPs. The contrast enhancement was assessed on the basis of loss of signal intensity in the stomach and duodenum. RESULTS: In the phantom experiment, a significant increase of percentage of signal intensity loss (PSIL) occurred in concentration of 22.4 ugFe/ml (Feridex 1 ml diluted with water 500 ml). Postcontrast MRCP showed an improved image quality compared with precontrast images. The rate of improvement in the diagnosis of diseases of the common bile duct and pancreatic duct was 25% (12/48). CONCLUSION: In patients with suspected biliary tract and pancreatic diseases, the SPIO is useful as a negative oral contrast agent for MRCP and provides an improvement of image quality.
